GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ABL Bio Inc (XKRX:298380) » Definitions » Other Current Payables

ABL Bio (XKRX:298380) Other Current Payables : ₩7,713 Mil (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is ABL Bio Other Current Payables?

ABL Bio's Other Current Payables for the quarter that ended in Mar. 2024 was ₩7,713 Mil.

ABL Bio's quarterly Other Current Payables increased from Sep. 2023 (₩6,217 Mil) to Dec. 2023 (₩8,547 Mil) but then declined from Dec. 2023 (₩8,547 Mil) to Mar. 2024 (₩7,713 Mil).

ABL Bio's annual Other Current Payables increased from Dec. 2021 (₩5,678 Mil) to Dec. 2022 (₩6,372 Mil) and increased from Dec. 2022 (₩6,372 Mil) to Dec. 2023 (₩8,547 Mil).


ABL Bio Other Current Payables Historical Data

The historical data trend for ABL Bio's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ABL Bio Other Current Payables Chart

ABL Bio Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Current Payables
Get a 7-Day Free Trial 1,464.93 2,864.92 5,677.65 6,371.81 8,546.82

ABL Bio Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6,143.97 9,135.23 6,217.21 8,546.82 7,713.36

ABL Bio Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.


ABL Bio Other Current Payables Related Terms

Thank you for viewing the detailed overview of ABL Bio's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.


ABL Bio (XKRX:298380) Business Description

Traded in Other Exchanges
N/A
Address
2nd Floor, 16 Daewangpangyo-Ro 712, Beon-Gil, Bundang-Gu, Gyeonggi-do, Seongnam-si, KOR, 13488
ABL Bio Inc is a Korean biotech research company. The company is engaged in the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline products include ABL001 an Bispecific Antibody, ABL201-205 an Antibody Drug Conjugate, T cell engager, Dual Immune Cell Targeting BsAb an Immuno-Oncology, ABL301 an BBB-Penetrating Bispecific Antibody.

ABL Bio (XKRX:298380) Headlines

No Headlines